6-[5-Fluoro-1-(propan-2-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-ylidene]-2-methylcyclohexa-2,4-dien-1-imine

Catalog No. :
ACNQZM451
CAS No. :
1356781-02-6
Molecular Formula :
C17H18FN3
Molecular Weight :
283.35

IUPAC Name:(E)-6-(5-fluoro-1-isopropyl-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)-2-methylcyclohexa-2,4-dien-1-imine

6-[5-Fluoro-1-(propan-2-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-ylidene]-2-methylcyclohexa-2,4-dien-1-imine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$195.00Login to see priceInquiryInquiry
250mg95%$270.00Login to see priceInquiryInquiry
1g95%$526.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-[5-Fluoro-1-(propan-2-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-ylidene]-2-methylcyclohexa-2,4-dien-1-imine
IUPAC Name(E)-6-(5-fluoro-1-isopropyl-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)-2-methylcyclohexa-2,4-dien-1-imine
MDL No.MFCD20441655
Molecular FormulaC17H18FN3
Molecular Weight283.35
SMILESCC1=CC=C/C(=C2/NC3=CC(F)=CC=C3N2C(C)C)C1=N
InChI KeyVAWSIBNIAHONSO-PRYCOQAESA-N
Synonym6-[5-fluoro-1-(propan-2-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-ylidene]-2-methylcyclohexa-2,4-dien-1-imine;2,4-Cyclohexadien-1-imine, 6-[5-fluoro-1,3-dihydro-1-(1-methylethyl)-2H-benzimidazol-2-ylidene]-2-methyl-
CAS No.1356781-02-6

Synthetic Route by SureRoute

1. ACNQZM451 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACNQZM451 route product structure diagram
    ACNQZM4511356781-02-6
Inquiry

2. ACNQZM451 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNQZM451 route product structure diagram
    ACNQZM4511356781-02-6
Inquiry

Comments (0)